Description
Regular Meeting
The Cambridge Biosafety Committee meeting meets on a monthly basis so that members may conduct its oversight activities as granted under the Cambridge Recombinant DNA Technology Ordinance (Chapter 8.20) and the Cambridge Biosafety Regulation of 2009.
AGENDA (Link to PDF)
Cambridge Biosafety Committee
Thursday, Feb 20, 2020 – 3:00 pm
119 Windsor Street
Introductions
Presentations
Lilly Cambridge Innovation Center (Consuelo Davis, Rebecca Miles) will present a request for a new BSL-1/BSL-2 permit for their facility at 450 Kendall Street, 2nd Floor
Pyxis Oncology (Dan Felitsky) will present a request for a new BSL-2 ONLY permit for their facility at 35 CambridgePark Drive
ATPase (Andrew Garner) will present a request for a new BSL-1/BSL-2 permit for their facility at 215 First Street, 1st Floor
VL50/VL59/Flagship 60 (Annette Huebner/Marie Didiot/Bilada Bilican) will present a request for new BSL-2 ONLY permits for their shared facility at One Kendall Square, Suite 7201 (Bldg 600/700, 2nd Floor). Flagship 60 is already permitted, but seeks an amendment.
Old Business/Site visits
Jan 22 – Elicio Therapeutics (One Kendall Square Bldg 1400W, 3rd Floor) new BSL-2 ONLY permit walkthrough
Jan 27 – Trisaq, Inc. (One Kendall Square Suite 7102) new BSL-2 ONLY permit walkthrough
Jan 28 – FL68, Inc. (26 Landsdowne Street, 4th Floor) new BSL-2 ONLY permit walkthrough (shared space hosted by Cogen)
Jan 28 – Glympse Bio (35 CambridgePark Drive, Suite 100) new BSL-1/BSL-2 permit
Feb 6 – Simcere Innovaton (20 Acord Park, 2nd Floor) new BSL-2 ONLY permit walkthrough
Feb 7 – Double Rainbow (840 Memorial Drive, 1st Floor) amendment BSL-1/BSL-2 (from BSL-1) walkthrough
Feb 14 – Civetta (10 Wilson Rd, 2nd Floor) new BSL-2 ONLY permit walkthrough
New Business
Adjourn